Rodney Flores-Lefranc is a notable inventor based in Round Rock, TX (US). He has made significant contributions to the field of therapeutic molecules, particularly in the development of multivalent CD20-binding molecules. With a total of 3 patents, his work focuses on innovative solutions for treating various diseases, including cancer and immune disorders.

Latest Patents

Rodney's latest patents include groundbreaking inventions such as a multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof. This invention provides multivalent CD20-binding molecules and compositions for selective killing of specific cell types and therapeutic applications. These molecules can deliver agents into CD20-expressing cells, collect diagnostic information, and monitor treatments for diseases like cancers and immune disorders. Another significant patent involves multivalent CD20-binding molecules that comprise two or more CD20-binding regions and Shiga toxin effector polypeptide regions. This invention also aims to enhance therapeutic efficacy against various diseases.

Career Highlights

Rodney Flores-Lefranc is currently associated with Molecular Templates, Inc., where he continues to innovate in the field of therapeutic molecules. His work has garnered attention for its potential impact on treatment methodologies for serious health conditions.

Collaborations

Rodney collaborates with esteemed colleagues such as Eric Poma and Erin Willert, contributing to a dynamic research environment that fosters innovation and development in therapeutic solutions.

Conclusion

Rodney Flores-Lefranc stands out as a key inventor in the realm of therapeutic molecules, with a focus on addressing critical health challenges through his innovative patents. His contributions are paving the way for advancements in medical treatments and diagnostics.

Profile summary based on public USPTO records.